CervoMed Inc.
CRVO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001053691
No open-market purchases or sales by CervoMed Inc. insiders were filed in the last 90 days; 37 institutions reported holding it in 13F filings for Q2 2026, worth $5.42M in total; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding CervoMed Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 38 | 1 | 50 | +13 |
| Shares | 3.45M | 303.9K | 3.51M | +362.7K (+11.5%) |
| Value | $59.0M | $5.20M | $51.2M | −$2.62M (−4.9%) |
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (16)
Institutions that held CervoMed Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BlackRock, Inc. | 318,766 | $4.65M | 0.00% |
| Northern Trust Corp | 53,692 | $783.9K | 0.00% |
| Nuveen Asset Management, LLC | 19,465 | $284.2K | 0.00% |
| Millennium Management LLC | 15,569 | $227.3K | 0.00% |
| Citadel Advisors LLC | 12,493 | $182.4K | 0.00% |
| Sherbrooke Park Advisers LLC | 11,766 | $171.8K | 0.04% |
| Marshall Wace, LLP | 11,657 | $170.2K | 0.00% |
| FMR LLC | 3,863 | $56.4K | 0.00% |
| Mirae Asset Global ETFs Holdings Ltd. | 3,006 | $43.9K | 0.00% |
| Russell Investments Group, Ltd. | 1,195 | $17.4K | 0.00% |
| Tower Research Capital LLC (TRC) | 557 | $8.13K | 0.00% |
| DT Investment Partners, LLC | 142 | $2.07K | 0.00% |
| Sterling Capital Management LLC | 6 | $88 | 0.00% |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 2 | $29 | 0.00% |
| Danske Bank A/S | 1 | $15 | 0.00% |
| Capital Advisors, Ltd. LLC | 33 | $0 | 0.00% |
Sold out (3)
Institutions that held CervoMed Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Bank of New York Mellon Corp | 13,784 | $236.0K |
| Fred Alger Management, LLC | 3,500 | $59.9K |
| Manchester Capital Management LLC | 138 | $2.36K |
Not filed for Q3 2024 yet (1)
Institutions that held CervoMed Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 303,935 | $5.20M |